The efficacy of Liraglutide in patients with intestinal failure: a prospective, single-center, randomized controlled study

The efficacy of Liraglutide in patients with intestinal failure: a prospective, single-center, randomized, controlled, observational study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034159

Enrollment

Unknown

Registered

2020-06-26

Start date

2020-06-30

Completion date

Unknown

Last updated

2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with intestinal failure

Interventions

Control group:conventional therapy

Intervention group:Subcutaneous injection of Liraglutide and conventional therapy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 -80 years; 2. Patients with intestinal failure; 3. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe renal dysfunction; 2. Diabetes; 3. Women who are pregnant or breastfeeding; 4. Immunodeficiency, use of immunosuppressive agents and hormones; 5. Mental illness or inability to cooperate; 6. Has been selected by other clinical researchers.

Design outcomes

Primary

Measure	Time frame
Nutrition-related indicators;hepatic and renal function;Blood sugar and insulin resistance;	—

Secondary

Measure	Time frame
Body Composition, Bone Mineral Content, and Body Weight;Quality of Life;infectious complications;Inflammatory markers (CRP, IL-6, etc.);gastrointestinal complications;Energy and protein intake;Parenteral nutrition;	—

Countries

China

Contacts

Public ContactXuejin Gao

Jinling Hospital

547625433@qq.com+86 18251937684

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026